SCHEMBL9936662

SCHEMBL9936662

O=C(NC(Cc1ccc(-c2ccccc2)cc1)C[C@@H](O)C(=O)O)c1cc(-c2ccccc2Cl)on1

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MME P08473 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15464134 1.00 MME (0.81) MME
SCHEMBL15464077 0.96 MME (0.77) MME
SCHEMBL9937594 0.96 MME (0.77) MME
SCHEMBL9929778 0.90 MME (0.77) MME
SCHEMBL9937354 0.90 MME (0.77) MME
SCHEMBL15464021 0.89 MME (1.00) MME
SCHEMBL9929869 0.88 MME (0.76) MME
SCHEMBL9929650 0.86 MME (1.00) MME
SCHEMBL9937750 0.86 MME (1.00) MME
SCHEMBL15464036 0.85 MME (0.80) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651896-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-10-23 EP disclosed
WO-2012082853-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-06-21 WO disclosed